Insider · CIK 0001296999
David Arkowitz
Files at IBIO (iBio, Inc.), KANT (KINETA, INC./DE). First filing Jan 13, 2025, latest Jan 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IBIO: iBio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | iBio, Inc. | $50k 18,382 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | KANT KINETA, INC./DE | DDisposition to issuer Common Stock | -16,571 | - | - | 0 | Jul 2, 2025 |
| Jun 30, 2025 | KANT KINETA, INC./DE | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $0.00 | $0 | 0 | Jul 2, 2025 |
| Jun 30, 2025 | KANT KINETA, INC./DE | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,000 | $0.00 | $0 | 0 | Jul 2, 2025 |
| Jun 23, 2025 | KANT KINETA, INC./DE | MOption exercise Common Stock | +12,500 | $0.61 | $7,638 | 16,847 | Jun 25, 2025 |
| Jun 23, 2025 | KANT KINETA, INC./DE | FTax withholding Common Stock | -4,706 | $0.26 | $1,224 | 12,141 | Jun 25, 2025 |
| Jun 25, 2025 | KANT KINETA, INC./DE | AGrant or award Common Stock | +6,000 | $0.00 | $0 | 18,141 | Jun 25, 2025 |
| Jun 23, 2025 | KANT KINETA, INC./DE | MOption exercise Stock Option (Right to Buy)derivative | -12,500 | $0.00 | $0 | 0 | Jun 25, 2025 |
| Jan 10, 2025 | IBIO iBio, Inc. | POpen-market purchase Common Stock | +18,382 | $2.72 | $50k | 18,382 | Jan 13, 2025 |
| Nov 21, 2024 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,600 | $0.00 | $0 | 12,600 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.